Last 12 months
Inside the activity.
2 purchase rows · 5 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 2 |
| Apr 2026 | 0 | 0 |
| May 2026 | 1 | 2 |
| Jun 2026 | 1 | 1 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| August 15, 2025 Filed Aug 18, 2025 21:05 UTC |
Palandjian Tracy P.Director
|
Exercise / conversionStock Units · Derivative | 1,117 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-25-020597 · form4.xml · derivative · entry 2 Palandjian Tracy P. · CIK 0001543889 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,837 Underlying: Common Stock · 1,117 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Reflects the vesting of previously reported awards. Awards vest 2022-2027. F1 · derivative.exercise_date: Reflects the vesting of previously reported awards. Awards vest 2022-2027. F1 · derivative.expiration_date: Reflects the vesting of previously reported awards. Awards vest 2022-2027. F2 · balance_after: Inclusive of previously reported deferred stock units. Read SEC document |
| August 15, 2025 Filed Aug 18, 2025 21:05 UTC |
Palandjian Tracy P.Director
|
Exercise / conversionCommon Stock | 1,117 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-25-020597 · form4.xml · nonDerivative · entry 1 Palandjian Tracy P. · CIK 0001543889 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 17,886 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Reflects the vesting of previously reported awards. Awards vest 2022-2027. Read SEC document |
| August 14, 2025 Filed Aug 18, 2025 21:15 UTC |
Ryan David ChristopherDirector
|
GrantDeferred Stock Units · Derivative | 307 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-25-020602 · form4.xml · derivative · entry 2 Ryan David Christopher · CIK 0001725101 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 307 Underlying: Common Stock · 307 shares Expires not disclosed F2 · derivative.exercise_price: Reflects cash fees that the director has elected to defer under the Company's deferred compensation plan, which are notionally invested in a measurement fund tracking the Company's common stock during the deferral period. Each deferred stock unit is equal to one share of the Company's common stock, and becomes distributable in common stock upon the reporting person's separation from service as a member of the Board of Directors of the Company. F2 · derivative.exercise_date: Reflects cash fees that the director has elected to defer under the Company's deferred compensation plan, which are notionally invested in a measurement fund tracking the Company's common stock during the deferral period. Each deferred stock unit is equal to one share of the Company's common stock, and becomes distributable in common stock upon the reporting person's separation from service as a member of the Board of Directors of the Company. F2 · derivative.expiration_date: Reflects cash fees that the director has elected to defer under the Company's deferred compensation plan, which are notionally invested in a measurement fund tracking the Company's common stock during the deferral period. Each deferred stock unit is equal to one share of the Company's common stock, and becomes distributable in common stock upon the reporting person's separation from service as a member of the Board of Directors of the Company. Read SEC document |
| August 14, 2025 Filed Aug 18, 2025 21:13 UTC |
STARR LOREN MDirector
|
GrantDeferred Stock Units · Derivative | 334 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-25-020601 · form4.xml · derivative · entry 2 STARR LOREN M · CIK 0001217495 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 334 Underlying: Common Stock · 334 shares Expires not disclosed F2 · derivative.exercise_price: Reflects cash fees that the director has elected to defer under the Company's deferred compensation plan, which are notionally invested in a measurement fund tracking the Company's common stock during the deferral period. Each deferred stock unit is equal to one share of the Company's common stock, and becomes distributable in common stock upon the reporting person's separation from service as a member of the Board of Directors of the Company. F2 · derivative.exercise_date: Reflects cash fees that the director has elected to defer under the Company's deferred compensation plan, which are notionally invested in a measurement fund tracking the Company's common stock during the deferral period. Each deferred stock unit is equal to one share of the Company's common stock, and becomes distributable in common stock upon the reporting person's separation from service as a member of the Board of Directors of the Company. F2 · derivative.expiration_date: Reflects cash fees that the director has elected to defer under the Company's deferred compensation plan, which are notionally invested in a measurement fund tracking the Company's common stock during the deferral period. Each deferred stock unit is equal to one share of the Company's common stock, and becomes distributable in common stock upon the reporting person's separation from service as a member of the Board of Directors of the Company. Read SEC document |
| August 14, 2025 Filed Aug 18, 2025 21:11 UTC |
Alvingham Karen L.Director
|
GrantDeferred Stock Units · Derivative | 262 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-25-020600 · form4.xml · derivative · entry 3 Alvingham Karen L. · CIK 0001726148 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 262 Underlying: Common Stock · 262 shares Expires not disclosed F3 · derivative.exercise_price: Reflects cash fees that the director has elected to defer under the Company's deferred compensation plan, which are notionally invested in a measurement fund tracking the Company's common stock during the deferral period. Each deferred stock unit is equal to one share of the Company's common stock, and becomes distributable in common stock upon the reporting person's separation from service as a member of the Board of Directors of the Company. F3 · derivative.exercise_date: Reflects cash fees that the director has elected to defer under the Company's deferred compensation plan, which are notionally invested in a measurement fund tracking the Company's common stock during the deferral period. Each deferred stock unit is equal to one share of the Company's common stock, and becomes distributable in common stock upon the reporting person's separation from service as a member of the Board of Directors of the Company. F3 · derivative.expiration_date: Reflects cash fees that the director has elected to defer under the Company's deferred compensation plan, which are notionally invested in a measurement fund tracking the Company's common stock during the deferral period. Each deferred stock unit is equal to one share of the Company's common stock, and becomes distributable in common stock upon the reporting person's separation from service as a member of the Board of Directors of the Company. Read SEC document |
| August 12, 2025 Filed Aug 14, 2025 21:00 UTC |
Horgen Jay C.Director · Chief Executive Officer
|
Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 75,000 | $0.00 Strike: $74.49 | $0.00 |
DisclosureSEC source: 0001127602-25-020463 · form4.xml · derivative · entry 4 Horgen Jay C. · CIK 0001432993 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 150,000 Underlying: Common Stock · 75,000 shares Expires 2026-08-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 12, 2025 Filed Aug 14, 2025 21:00 UTC |
Horgen Jay C.Director · Chief Executive Officer
|
Tax withholdingCommon Stock | 45,607 | $219.70 | $10,019,857.90 |
DisclosureSEC source: 0001127602-25-020463 · form4.xml · nonDerivative · entry 2 Horgen Jay C. · CIK 0001432993 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 484,322 Read SEC document |
| August 12, 2025 Filed Aug 14, 2025 21:00 UTC |
Horgen Jay C.Director · Chief Executive Officer
|
Exercise / conversionCommon Stock | 75,000 | $74.49 | $5,586,750.00 |
DisclosureSEC source: 0001127602-25-020463 · form4.xml · nonDerivative · entry 1 Horgen Jay C. · CIK 0001432993 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 529,929 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 31, 2025 Filed Aug 4, 2025 21:34 UTC |
STARR LOREN MDirector
|
GrantRestricted Stock Units · Derivative | 716 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-25-020019 · form4.xml · derivative · entry 1 STARR LOREN M · CIK 0001217495 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 716 Underlying: Common Stock · 716 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a right to receive one share of the Company's common stock upon vesting. The restricted stock units vest in full on August 15, 2026. F1 · derivative.exercise_date: Each restricted stock unit represents a right to receive one share of the Company's common stock upon vesting. The restricted stock units vest in full on August 15, 2026. F1 · derivative.expiration_date: Each restricted stock unit represents a right to receive one share of the Company's common stock upon vesting. The restricted stock units vest in full on August 15, 2026. Read SEC document |
| July 31, 2025 Filed Aug 4, 2025 21:33 UTC |
Palandjian Tracy P.Director
|
GrantRestricted Stock Units · Derivative | 477 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-25-020018 · form4.xml · derivative · entry 1 Palandjian Tracy P. · CIK 0001543889 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 477 Underlying: Common Stock · 477 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a right to receive one share of the Company's common stock upon vesting. The restricted stock units vest in full on August 15, 2026. F1 · derivative.exercise_date: Each restricted stock unit represents a right to receive one share of the Company's common stock upon vesting. The restricted stock units vest in full on August 15, 2026. F1 · derivative.expiration_date: Each restricted stock unit represents a right to receive one share of the Company's common stock upon vesting. The restricted stock units vest in full on August 15, 2026. Read SEC document |
| July 31, 2025 Filed Aug 4, 2025 21:32 UTC |
Ryan David ChristopherDirector
|
GrantRestricted Stock Units · Derivative | 477 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-25-020016 · form4.xml · derivative · entry 1 Ryan David Christopher · CIK 0001725101 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 477 Underlying: Common Stock · 477 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a right to receive one share of the Company's common stock upon vesting. The restricted stock units vest in full on August 15, 2026. F1 · derivative.exercise_date: Each restricted stock unit represents a right to receive one share of the Company's common stock upon vesting. The restricted stock units vest in full on August 15, 2026. F1 · derivative.expiration_date: Each restricted stock unit represents a right to receive one share of the Company's common stock upon vesting. The restricted stock units vest in full on August 15, 2026. Read SEC document |
| July 31, 2025 Filed Aug 4, 2025 21:31 UTC |
FRANQUI ANNETTEDirector
|
GrantRestricted Stock Units · Derivative | 477 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-25-020013 · form4.xml · derivative · entry 1 FRANQUI ANNETTE · CIK 0001849146 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 477 Underlying: Common Stock · 477 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a right to receive one share of the Company's common stock upon vesting. The restricted stock units vest in full on August 15, 2026. F1 · derivative.exercise_date: Each restricted stock unit represents a right to receive one share of the Company's common stock upon vesting. The restricted stock units vest in full on August 15, 2026. F1 · derivative.expiration_date: Each restricted stock unit represents a right to receive one share of the Company's common stock upon vesting. The restricted stock units vest in full on August 15, 2026. Read SEC document |
| July 31, 2025 Filed Aug 4, 2025 21:30 UTC |
Matos Rodriguez Felix V.Director
|
GrantRestricted Stock Units · Derivative | 477 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-25-020011 · form4.xml · derivative · entry 1 Matos Rodriguez Felix V. · CIK 0001838275 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 477 Underlying: Common Stock · 477 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a right to receive one share of the Company's common stock upon vesting. The restricted stock units vest in full on August 15, 2026. F1 · derivative.exercise_date: Each restricted stock unit represents a right to receive one share of the Company's common stock upon vesting. The restricted stock units vest in full on August 15, 2026. F1 · derivative.expiration_date: Each restricted stock unit represents a right to receive one share of the Company's common stock upon vesting. The restricted stock units vest in full on August 15, 2026. Read SEC document |
| July 31, 2025 Filed Aug 4, 2025 21:29 UTC |
Churchill Dwight D.Director
|
GrantRestricted Stock Units · Derivative | 477 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-25-020009 · form4.xml · derivative · entry 1 Churchill Dwight D. · CIK 0001486072 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 477 Underlying: Common Stock · 477 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a right to receive one share of the Company's common stock upon vesting. The restricted stock units vest in full on August 15, 2026. F1 · derivative.exercise_date: Each restricted stock unit represents a right to receive one share of the Company's common stock upon vesting. The restricted stock units vest in full on August 15, 2026. F1 · derivative.expiration_date: Each restricted stock unit represents a right to receive one share of the Company's common stock upon vesting. The restricted stock units vest in full on August 15, 2026. Read SEC document |
| July 31, 2025 Filed Aug 4, 2025 21:28 UTC |
Alvingham Karen L.Director
|
GrantRestricted Stock Units · Derivative | 477 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-25-020004 · form4.xml · derivative · entry 1 Alvingham Karen L. · CIK 0001726148 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 477 Underlying: Common Stock · 477 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a right to receive one share of the Company's common stock upon vesting. The restricted stock units vest in full on August 15, 2026. F1 · derivative.exercise_date: Each restricted stock unit represents a right to receive one share of the Company's common stock upon vesting. The restricted stock units vest in full on August 15, 2026. F1 · derivative.expiration_date: Each restricted stock unit represents a right to receive one share of the Company's common stock upon vesting. The restricted stock units vest in full on August 15, 2026. Read SEC document |
| July 02, 2025 Filed Jul 3, 2025 18:10 UTC |
Horgen Jay C.Director · Chief Executive Officer
|
GiftCommon Stock | 14,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-25-018821 · form4.xml · nonDerivative · entry 4 Horgen Jay C. · CIK 0001432993 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Indirect · By Family Trusts Disclosed balance after: 34,058 F1 · shares: The reporting person transferred 14,000 shares to a family trust of which the reporting person and his spouse are trustees, and for which the reporting person and members of his immediate family are the beneficiaries. Read SEC document |
| July 02, 2025 Filed Jul 3, 2025 18:10 UTC |
Horgen Jay C.Director · Chief Executive Officer
|
GiftCommon Stock | 14,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-25-018821 · form4.xml · nonDerivative · entry 3 Horgen Jay C. · CIK 0001432993 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 454,929 F1 · shares: The reporting person transferred 14,000 shares to a family trust of which the reporting person and his spouse are trustees, and for which the reporting person and members of his immediate family are the beneficiaries. Read SEC document |
| July 01, 2025 Filed Jul 3, 2025 18:10 UTC |
Horgen Jay C.Director · Chief Executive Officer
|
Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 75,000 | $0.00 Strike: $74.49 | $0.00 |
DisclosureSEC source: 0001127602-25-018821 · form4.xml · derivative · entry 5 Horgen Jay C. · CIK 0001432993 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 225,000 Underlying: Common Stock · 75,000 shares Expires 2026-08-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 01, 2025 Filed Jul 3, 2025 18:10 UTC |
Horgen Jay C.Director · Chief Executive Officer
|
Tax withholdingCommon Stock | 47,191 | $198.72 | $9,377,795.52 |
DisclosureSEC source: 0001127602-25-018821 · form4.xml · nonDerivative · entry 2 Horgen Jay C. · CIK 0001432993 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 468,929 Read SEC document |
| July 01, 2025 Filed Jul 3, 2025 18:10 UTC |
Horgen Jay C.Director · Chief Executive Officer
|
Exercise / conversionCommon Stock | 75,000 | $74.49 | $5,586,750.00 |
DisclosureSEC source: 0001127602-25-018821 · form4.xml · nonDerivative · entry 1 Horgen Jay C. · CIK 0001432993 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 516,120 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 12, 2025 Filed May 13, 2025 21:06 UTC |
Churchill Dwight D.Director
|
Exercise / conversionDirector Stock Option (Right to Buy) · Derivative | 1,353 | $0.00 Strike: $160.01 | $0.00 |
DisclosureSEC source: 0001127602-25-014117 · form4.xml · derivative · entry 3 Churchill Dwight D. · CIK 0001486072 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,353 shares Expires 2025-07-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 12, 2025 Filed May 13, 2025 21:06 UTC |
Churchill Dwight D.Director
|
Tax withholdingCommon Stock | 1,178 | $183.83 | $216,551.74 |
DisclosureSEC source: 0001127602-25-014117 · form4.xml · nonDerivative · entry 2 Churchill Dwight D. · CIK 0001486072 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 27,632 Read SEC document |
| May 12, 2025 Filed May 13, 2025 21:06 UTC |
Churchill Dwight D.Director
|
Exercise / conversionCommon Stock | 1,353 | $160.01 | $216,493.53 |
DisclosureSEC source: 0001127602-25-014117 · form4.xml · nonDerivative · entry 1 Churchill Dwight D. · CIK 0001486072 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 28,810 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 12, 2025 Filed May 13, 2025 21:04 UTC |
Palandjian Tracy P.Director
|
Exercise / conversionDirector Stock Option (Right to Buy) · Derivative | 1,361 | $0.00 Strike: $86.78 | $0.00 |
DisclosureSEC source: 0001127602-25-014116 · form4.xml · derivative · entry 7 Palandjian Tracy P. · CIK 0001543889 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,361 shares Expires 2026-07-30 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 12, 2025 Filed May 13, 2025 21:04 UTC |
Palandjian Tracy P.Director
|
Exercise / conversionDirector Stock Option (Right to Buy) · Derivative | 1,787 | $0.00 Strike: $110.02 | $0.00 |
DisclosureSEC source: 0001127602-25-014116 · form4.xml · derivative · entry 6 Palandjian Tracy P. · CIK 0001543889 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,787 shares Expires 2026-02-05 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 12, 2025 Filed May 13, 2025 21:04 UTC |
Palandjian Tracy P.Director
|
Exercise / conversionDirector Stock Option (Right to Buy) · Derivative | 1,353 | $0.00 Strike: $160.01 | $0.00 |
DisclosureSEC source: 0001127602-25-014116 · form4.xml · derivative · entry 5 Palandjian Tracy P. · CIK 0001543889 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,353 shares Expires 2025-07-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 12, 2025 Filed May 13, 2025 21:04 UTC |
Palandjian Tracy P.Director
|
Tax withholdingCommon Stock | 2,891 | $183.83 | $531,452.53 |
DisclosureSEC source: 0001127602-25-014116 · form4.xml · nonDerivative · entry 4 Palandjian Tracy P. · CIK 0001543889 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 16,769 Read SEC document |
| May 12, 2025 Filed May 13, 2025 21:04 UTC |
Palandjian Tracy P.Director
|
Exercise / conversionCommon Stock | 1,361 | $86.78 | $118,107.58 |
DisclosureSEC source: 0001127602-25-014116 · form4.xml · nonDerivative · entry 3 Palandjian Tracy P. · CIK 0001543889 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 19,660 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 12, 2025 Filed May 13, 2025 21:04 UTC |
Palandjian Tracy P.Director
|
Exercise / conversionCommon Stock | 1,787 | $110.02 | $196,605.74 |
DisclosureSEC source: 0001127602-25-014116 · form4.xml · nonDerivative · entry 2 Palandjian Tracy P. · CIK 0001543889 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 18,299 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 12, 2025 Filed May 13, 2025 21:04 UTC |
Palandjian Tracy P.Director
|
Exercise / conversionCommon Stock | 1,353 | $160.01 | $216,493.53 |
DisclosureSEC source: 0001127602-25-014116 · form4.xml · nonDerivative · entry 1 Palandjian Tracy P. · CIK 0001543889 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 16,512 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 09, 2025 Filed May 13, 2025 21:07 UTC |
Padiyar KavitaGeneral Counsel & Corp. Sec.
|
Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 25,000 | $0.00 Strike: $73.81 | $0.00 |
DisclosureSEC source: 0001127602-25-014118 · form4.xml · derivative · entry 3 Padiyar Kavita · CIK 0002017736 · General Counsel & Corp. Sec. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 49,085 Underlying: Common Stock · 25,000 shares Expires 2027-03-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 09, 2025 Filed May 13, 2025 21:07 UTC |
Padiyar KavitaGeneral Counsel & Corp. Sec.
|
Tax withholdingCommon Stock | 17,407 | $179.17 | $3,118,812.19 |
DisclosureSEC source: 0001127602-25-014118 · form4.xml · nonDerivative · entry 2 Padiyar Kavita · CIK 0002017736 · General Counsel & Corp. Sec. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 25,700 Read SEC document |
| May 09, 2025 Filed May 13, 2025 21:07 UTC |
Padiyar KavitaGeneral Counsel & Corp. Sec.
|
Exercise / conversionCommon Stock | 25,000 | $73.81 | $1,845,250.00 |
DisclosureSEC source: 0001127602-25-014118 · form4.xml · nonDerivative · entry 1 Padiyar Kavita · CIK 0002017736 · General Counsel & Corp. Sec. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 43,107 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 05, 2025 Filed Mar 7, 2025 22:15 UTC |
Horgen Jay C.Director · President and CEO
|
GrantStock Units · Derivative | 13,527 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-25-008757 · form4.xml · derivative · entry 6 Horgen Jay C. · CIK 0001432993 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,527 Underlying: Common Stock · 13,527 shares Expires not disclosed F4 · derivative.exercise_price: The award, issued under the Company's 2020 Equity Incentive Plan, vests in four equal installments on each of March 5, 2026, 2027, 2028, and 2029. F4 · derivative.exercise_date: The award, issued under the Company's 2020 Equity Incentive Plan, vests in four equal installments on each of March 5, 2026, 2027, 2028, and 2029. F4 · derivative.expiration_date: The award, issued under the Company's 2020 Equity Incentive Plan, vests in four equal installments on each of March 5, 2026, 2027, 2028, and 2029. Read SEC document |
| March 05, 2025 Filed Mar 7, 2025 22:15 UTC |
Horgen Jay C.Director · President and CEO
|
Exercise / conversionStock Units · Derivative | 16,693 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-25-008757 · form4.xml · derivative · entry 5 Horgen Jay C. · CIK 0001432993 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 26,927 Underlying: Common Stock · 16,693 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Reflects the vesting of previously reported awards. Awards vest 2022-2028. F1 · derivative.exercise_date: Reflects the vesting of previously reported awards. Awards vest 2022-2028. F1 · derivative.expiration_date: Reflects the vesting of previously reported awards. Awards vest 2022-2028. Read SEC document |
| March 05, 2025 Filed Mar 7, 2025 22:15 UTC |
Horgen Jay C.Director · President and CEO
|
Tax withholdingCommon Stock | 26,570 | $165.72 | $4,403,180.40 |
DisclosureSEC source: 0001127602-25-008757 · form4.xml · nonDerivative · entry 3 Horgen Jay C. · CIK 0001432993 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 441,120 F3 · shares: Reflects the automatic surrender of shares of common stock to the Company to satisfy tax withholding obligations related to the vesting of the awards described above. Read SEC document |
| March 05, 2025 Filed Mar 7, 2025 22:15 UTC |
Horgen Jay C.Director · President and CEO
|
GrantCommon Stock | 48,251 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-25-008757 · form4.xml · nonDerivative · entry 2 Horgen Jay C. · CIK 0001432993 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 467,690 F2 · price: Award granted in March 2022, which settled following the achievement of performance conditions previously described in the Company's annual meeting proxy statements. Read SEC document |
| March 05, 2025 Filed Mar 7, 2025 22:15 UTC |
Horgen Jay C.Director · President and CEO
|
Exercise / conversionCommon Stock | 16,693 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-25-008757 · form4.xml · nonDerivative · entry 1 Horgen Jay C. · CIK 0001432993 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 419,439 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Reflects the vesting of previously reported awards. Awards vest 2022-2028. Read SEC document |
| March 05, 2025 Filed Mar 7, 2025 22:13 UTC |
Padiyar KavitaGeneral Counsel & Corp. Sec.
|
GrantStock Units · Derivative | 1,293 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-25-008753 · form4.xml · derivative · entry 5 Padiyar Kavita · CIK 0002017736 · General Counsel & Corp. Sec. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,293 Underlying: Common Stock · 1,293 shares Expires not disclosed F4 · derivative.exercise_price: The award, issued under the Company's 2020 Equity Incentive Plan, vests in four equal installments on each of March 5, 2026, 2027, 2028, and 2029. F4 · derivative.exercise_date: The award, issued under the Company's 2020 Equity Incentive Plan, vests in four equal installments on each of March 5, 2026, 2027, 2028, and 2029. F4 · derivative.expiration_date: The award, issued under the Company's 2020 Equity Incentive Plan, vests in four equal installments on each of March 5, 2026, 2027, 2028, and 2029. Read SEC document |
| March 05, 2025 Filed Mar 7, 2025 22:13 UTC |
Padiyar KavitaGeneral Counsel & Corp. Sec.
|
Exercise / conversionStock Units · Derivative | 2,236 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-25-008753 · form4.xml · derivative · entry 4 Padiyar Kavita · CIK 0002017736 · General Counsel & Corp. Sec. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,665 Underlying: Common Stock · 2,236 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Reflects the vesting of previously reported awards. Awards vest 2022-2028. F1 · derivative.exercise_date: Reflects the vesting of previously reported awards. Awards vest 2022-2028. F1 · derivative.expiration_date: Reflects the vesting of previously reported awards. Awards vest 2022-2028. Read SEC document |
| March 05, 2025 Filed Mar 7, 2025 22:13 UTC |
Padiyar KavitaGeneral Counsel & Corp. Sec.
|
Tax withholdingCommon Stock | 2,630 | $165.72 | $435,843.60 |
DisclosureSEC source: 0001127602-25-008753 · form4.xml · nonDerivative · entry 3 Padiyar Kavita · CIK 0002017736 · General Counsel & Corp. Sec. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 18,107 F3 · shares: Reflects the automatic surrender of shares of common stock to the Company to satisfy tax withholding obligations related to the vesting of the awards described above. Read SEC document |
| March 05, 2025 Filed Mar 7, 2025 22:13 UTC |
Padiyar KavitaGeneral Counsel & Corp. Sec.
|
GrantCommon Stock | 3,252 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-25-008753 · form4.xml · nonDerivative · entry 2 Padiyar Kavita · CIK 0002017736 · General Counsel & Corp. Sec. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20,737 F2 · price: Award granted in March 2022, which settled following the achievement of performance conditions previously described in the Company's annual meeting proxy statements. Read SEC document |
| March 05, 2025 Filed Mar 7, 2025 22:13 UTC |
Padiyar KavitaGeneral Counsel & Corp. Sec.
|
Exercise / conversionCommon Stock | 2,236 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-25-008753 · form4.xml · nonDerivative · entry 1 Padiyar Kavita · CIK 0002017736 · General Counsel & Corp. Sec. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 17,485 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Reflects the vesting of previously reported awards. Awards vest 2022-2028. Read SEC document |
| March 05, 2025 Filed Mar 7, 2025 22:10 UTC |
Wojcik Thomas MChief Operating Officer
|
GrantStock Units · Derivative | 5,900 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-25-008748 · form4.xml · derivative · entry 5 Wojcik Thomas M · CIK 0001776685 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,900 Underlying: Common Stock · 5,900 shares Expires not disclosed F4 · derivative.exercise_price: The award, issued under the Company's 2020 Equity Incentive Plan, vests in four equal installments on each of March 5, 2026, 2027, 2028, and 2029. F4 · derivative.exercise_date: The award, issued under the Company's 2020 Equity Incentive Plan, vests in four equal installments on each of March 5, 2026, 2027, 2028, and 2029. F4 · derivative.expiration_date: The award, issued under the Company's 2020 Equity Incentive Plan, vests in four equal installments on each of March 5, 2026, 2027, 2028, and 2029. Read SEC document |
| March 05, 2025 Filed Mar 7, 2025 22:10 UTC |
Wojcik Thomas MChief Operating Officer
|
Exercise / conversionStock Units · Derivative | 7,287 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-25-008748 · form4.xml · derivative · entry 4 Wojcik Thomas M · CIK 0001776685 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,918 Underlying: Common Stock · 7,287 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Reflects the vesting of previously reported awards. Awards vest 2022-2028. F1 · derivative.exercise_date: Reflects the vesting of previously reported awards. Awards vest 2022-2028. F1 · derivative.expiration_date: Reflects the vesting of previously reported awards. Awards vest 2022-2028. Read SEC document |
| March 05, 2025 Filed Mar 7, 2025 22:10 UTC |
Wojcik Thomas MChief Operating Officer
|
Tax withholdingCommon Stock | 14,220 | $165.72 | $2,356,538.40 |
DisclosureSEC source: 0001127602-25-008748 · form4.xml · nonDerivative · entry 3 Wojcik Thomas M · CIK 0001776685 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 119,415 F3 · shares: Reflects the automatic surrender of shares of common stock to the Company to satisfy tax withholding obligations related to the vesting of the awards described above. Read SEC document |
| March 05, 2025 Filed Mar 7, 2025 22:10 UTC |
Wojcik Thomas MChief Operating Officer
|
GrantCommon Stock | 20,555 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-25-008748 · form4.xml · nonDerivative · entry 2 Wojcik Thomas M · CIK 0001776685 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 133,635 F2 · price: Award granted in March 2022, which settled following the achievement of performance conditions previously described in the Company's annual meeting proxy statements. Read SEC document |
| March 05, 2025 Filed Mar 7, 2025 22:10 UTC |
Wojcik Thomas MChief Operating Officer
|
Exercise / conversionCommon Stock | 7,287 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-25-008748 · form4.xml · nonDerivative · entry 1 Wojcik Thomas M · CIK 0001776685 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 113,080 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Reflects the vesting of previously reported awards. Awards vest 2022-2028. Read SEC document |
| March 05, 2025 Filed Mar 7, 2025 22:08 UTC |
RITCHEA DAVAChief Financial Officer
|
GrantStock Units · Derivative | 2,405 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-25-008744 · form4.xml · derivative · entry 1 Ritchea Dava · CIK 0001840457 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,405 Underlying: Common Stock · 2,405 shares Expires not disclosed F1 · derivative.exercise_price: The award, issued under the Company's 2020 Equity Incentive Plan, vests in four equal installments on each of March 5, 2026, 2027, 2028, and 2029. F1 · derivative.exercise_date: The award, issued under the Company's 2020 Equity Incentive Plan, vests in four equal installments on each of March 5, 2026, 2027, 2028, and 2029. F1 · derivative.expiration_date: The award, issued under the Company's 2020 Equity Incentive Plan, vests in four equal installments on each of March 5, 2026, 2027, 2028, and 2029. Read SEC document |
| March 05, 2025 Filed Mar 7, 2025 22:05 UTC |
Churchill Dwight D.Director
|
Exercise / conversionStock Units · Derivative | 1,535 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-25-008740 · form4.xml · derivative · entry 2 Churchill Dwight D. · CIK 0001486072 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,696 Underlying: Common Stock · 1,535 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Reflects the vesting of previously reported awards. Awards vest 2022-2027. F1 · derivative.exercise_date: Reflects the vesting of previously reported awards. Awards vest 2022-2027. F1 · derivative.expiration_date: Reflects the vesting of previously reported awards. Awards vest 2022-2027. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.